Digital technologies and AI are transforming pharmacovigilance, clinical documentation (eTMF), and regulatory operations. What This…

Upcoming GMP revisions emphasise digital traceability, data integrity, and supply-chain accountability. What This Means for…

The UK continues to refine its own regulatory pathways for manufacturers and wholesalers. This includes…

The European Commission is reshaping market-exclusivity periods, supply-chain duties, and orphan-drug incentives through the upcoming…